On the basis of indication type, the systemic inflammatory response syndrome treatment market is segmented into meningitis, urinary tract infection (UTI), pneumonia, hemorrhage, autoimmune diseases, and others. Out of which, revenue from the treatment of urinary tract infection holds the highest share as dehydration, high consumption of birth control pills, menopause, and frequent involvement in sexual activities are leading causes of UTI. Females are more prone to UTI as they have a shorter urethra than males as a result, which shortens the distance for bacteria to reach the bladder.
On the basis of end-users, the market is segmented into hospital & ambulatory surgical centers, specialty clinics, and others. Specialty clinics segment hold the highest share of the systemic inflammatory response syndrome treatment market as a considerable portion of the population with disease on a global level tend to choose healthcare facilities specializing in specific treatment.
Our in-depth analysis of the global market includes the following segments:
By Type |
|
By End User |
|
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?